- Home
- PKE vs KMDA Comparison
PKE vs KMDA Comparison
Compare PKE & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- KMDA
- Stock Information
- Founded
- PKE 1954
- KMDA 1990
- Country
- PKE United States
- KMDA Israel
- Employees
- PKE N/A
- KMDA N/A
- Industry
- PKE Military/Government/Technical
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- PKE Industrials
- KMDA Health Care
- Exchange
- PKE Nasdaq
- KMDA Nasdaq
- Market Cap
- PKE 297.8M
- KMDA 349.6M
- IPO Year
- PKE N/A
- KMDA N/A
- Fundamental
- Price
- PKE $15.24
- KMDA $5.87
- Analyst Decision
- PKE
- KMDA Strong Buy
- Analyst Count
- PKE 0
- KMDA 2
- Target Price
- PKE N/A
- KMDA $14.50
- AVG Volume (30 Days)
- PKE 47.0K
- KMDA 30.2K
- Earning Date
- PKE 01-07-2025
- KMDA 11-13-2024
- Dividend Yield
- PKE 3.33%
- KMDA N/A
- EPS Growth
- PKE N/A
- KMDA 124.29
- EPS
- PKE 0.34
- KMDA 0.27
- Revenue
- PKE $58,651,000.00
- KMDA $158,380,000.00
- Revenue This Year
- PKE N/A
- KMDA $15.38
- Revenue Next Year
- PKE N/A
- KMDA $6.18
- P/E Ratio
- PKE $44.82
- KMDA $21.16
- Revenue Growth
- PKE 5.81
- KMDA 4.52
- 52 Week Low
- PKE $11.96
- KMDA $4.74
- 52 Week High
- PKE $16.96
- KMDA $6.53
- Technical
- Relative Strength Index (RSI)
- PKE 55.50
- KMDA 52.31
- Support Level
- PKE $14.77
- KMDA $5.71
- Resistance Level
- PKE $15.35
- KMDA $5.90
- Average True Range (ATR)
- PKE 0.33
- KMDA 0.16
- MACD
- PKE -0.04
- KMDA -0.03
- Stochastic Oscillator
- PKE 60.77
- KMDA 40.35
About PKE Park Aerospace Corp.
Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.